The 78-unit, mixed-income building will have 54 affordable apartments. The finance committee approved $14 million in TIF funds for the project Monday.

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...

Ayvens, a provider of sustainable mobility, delivered robust financial results for Q4 and full year 2024, marked by significant margin recovery, cost synergies, and progress in its integration roadmap ...

X-ALD is a rare and debilitating metabolic disorder ... we would plan to use multiple doses and conform in that we would target a 52-week treatment window as well. But we'll provide further ...

Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...

36 C.F.R. § 261.52(e). Being on any National Forest System ... The area is lawfully closed to public access. ALD-MENDOCINO, LAC-E167, ALD-WHITEPARK, ALD-FARNSWORTH, ALD-LAUREL, ALD-CHANEY ...

Cady says the Oxford PE-ALD machine is a step up for the Innovation ... federal government through the CHIPS and Science Act, a $52 billion fund passed by Congress in 2023 to help “reshore ...

S&P/ASX 200 Index (ASX: XJO) energy stock Ampol Ltd (ASX: ALD) is taking a tumble today ... That's down 56% from the US$10.52 per barrel achieved in 4Q 2023. Management noted this decline ...

3 Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China Correspondence to Dr Xingtao Zhou, Department of Ophthalmology and Optometry, Fudan University Eye Ear Nose and Throat ...

New Analysis Of Atomic Layer Deposition Equipment (ALD) Market overview, spend analysis, imports, segmentation, key players and opportunity analysis 2025-2033. It highlights significant observations, ...

Sales of China-based makers of chipmaking tools AMEC, Naura, and ACM Research expect record sales in 2024 amid curbs for Western companies to supply to China.

Fintel reports that on February 7, 2025, Citigroup initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Neutral ...